CU Gynecologic Oncology Research
banner
cugynonc.bsky.social
CU Gynecologic Oncology Research
@cugynonc.bsky.social
University of Colorado Anschutz gynecologic oncologists and researchers committed to advancing the future of women’s health. Focused on innovating early detection, prevention, and treatment through cutting-edge research. #GynOncology #CUAnschutz
Congrats to Dr. Bitler and Courtney Bailey, PhD candidate, on receiving a Grubstake Award from the CU Gates Institute! 🎉Their project, “Macrophage Backpacks for Delivering Olaparib to HGSC,” was awarded $300,000 over 2 years. bit.ly/4jXkQgW

@uccc-gorg.bsky.social @courtneybailey.bsky.social
January 26, 2026 at 10:08 PM
The 2024 Ovarian Cancer Think Tank brought experts together to tackle questions in #GynOnc research. Explore key insights in the white paper - Ovarian Cancer Think Tank: The Use of Integrated AI and Computational Biology in Ovarian Cancer Diagnosis and Treatment #CUAnschutz
bit.ly/4pBuYx7
Ovarian cancer think tank: the use of integrated artificial intelligence and computational biology in ovarian cancer diagnosis and treatment
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal, which is currently indexed in SCIE, etc. It covers many aspects of gynaecologic oncology top...
bit.ly
January 16, 2026 at 3:37 PM
Welcome Lily Elizabeth Feldman, PhD! 🎉
Lily joins Dr. Bitler’s Gyn Oncology Research Group (GORG) at CU Anschutz as a new postdoctoral fellow. She completed her PhD in Pharmacology & Molecular Medicine and is also the Faculty Innovations Program Director at CU Innovations. 🧬
#CUAnschutz #GynOnc
January 9, 2026 at 10:16 PM
🎗️Are you a gynecological cancer patient, survivor, caregiver, or provider? This conference is for you!

Hope & Healing: Gyn Cancer Survivorship & Beyond
🗓️ Thurs, Feb 5, 2026 
📍 CU Anschutz
🔗Registration link: loom.ly/sltGLsw

#CUAnschutz #Ovarian #Uterine #Endometrial #Cervical #Vulvar #Fallopian
January 6, 2026 at 6:46 PM
Congrats to Scott Lin, MD, PhD Candidate, on being accepted into the PhRMA Foundation’s Predoctoral Drug Discovery Fellowship🎉50 researchers are selected for a share of $3.7M in funding to shape the future of drug discovery & translational medicine🌟 #GynOnc #CUAnschutz

View Article: bit.ly/4aaHUX0
December 10, 2025 at 8:42 PM
Drs. Brad Corr and Ben Bitler launched a Phase 1 clinical trial for a promising combination therapy to tackle resistant ovarian cancer. This groundbreaking research could offer new hope to patients #OvarianCancer #GynOnc #CUAnschutz 🧬🎉

Read the Press Release: bit.ly/3MjeXxY
@uccc-gorg.bsky.social
From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy for Resistant Ovarian Cancer
From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy for Resistant Ovarian Cancer
bit.ly
December 4, 2025 at 3:35 PM
Exciting news🎉 Courtney Bailey, a CU Anschutz Gates Institute Grubstake Award finalist and PhD student, will present her research "Macrophage Backpacks for Delivering Olaparib to #HGSCs" on Nov 20, 4–6 PM at CU Innovations Executive Conference Room in the AHSB. #CUGynOnc @courtneybailey.bsky.social
November 10, 2025 at 3:24 PM
Levi Watson, PhD, will be presenting on “Hematopoietic Stem Cell–Derived Adipocytes Influence the Ovarian Cancer Microenvironment” at the Ovarian Cancer Midwest Focus (OCMF) Conference in Minneapolis, MN, on November 10–11, 2025. For more information, visit: bit.ly/3JJy1oa

#CUAnschutz #GynOnc
November 5, 2025 at 9:39 PM
CU Gynecologic Oncology was proud to join the HERA Ovarian Cancer Foundation’s Climb4Life & Gala! 🌄 Dr. Kian Behbakht spoke at the event & Taylor Benson, PhD, shared her HERA-funded research on WNT4 and metabolic biomarkers in #ovariancancer. 💙

For more information: bit.ly/3Lg6aMP
#CUAnschutz
October 30, 2025 at 2:52 PM
✨Dr. Brad Corr, A CU Gynecologic Oncologist, is dispelling clinical trial myths! 🧪✅ Safe, innovative treatments empower patients to make informed care decisions.

📖 Read more: bit.ly/4hAKCGW 

#OvarianCancer #GynOnc #CUAnschutz
Debunking 8 Myths About Cancer Clinical Trials
Misunderstandings about cancer clinical trials – what they are and how they work – keep some people from accessing the life-saving treatments they offer.
bit.ly
October 27, 2025 at 6:14 PM
Join us for the Pharmacology Seminar Series as Dr. Elizabeth Woodruff discusses how chronic stress influences #HGSC progression and immune response through adrenergic signaling in the omentum. #OvarianCancer #GynOnc #CUAnschutz

Date 📅: Mon, 10/20/25, 12:00 PM MST
Location📍: RC1 North, Room 6107
October 16, 2025 at 4:51 PM
✨Dr. Christine Walsh, a leading Gynecologic Oncologist at the University of Colorado Anschutz, recently appeared on 9News to discuss genetics' role in gyn cancers as well as share insights on ovarian cancer.

👉 Watch the full interviews here: bit.ly/3KNj0lv 

#CancerGenetics #GynOc #CUAnschutz
October 14, 2025 at 3:50 PM
Toni Moses, RN, is battling stage IV ovarian cancer while helping others—and participating in a trial led by Dr. Brad Corr & the CU Ovarian Cancer Innovations Group. 💙 Read her powerful story: news.cuanschutz.edu/cancer-cente...

#OvarianCancer #GynOnc #CUAnschutz
‘I Love What I Do’: While She Helps Patients, a Nurse Grapples with Her Own Ovarian Cancer
Toni Moses, RN, says she’s grateful to be enrolled in a clinical trial led by Bradley Corr, MD, of the CU Cancer Center.
news.cuanschutz.edu
October 1, 2025 at 7:16 PM
Thank you to all who attended the CU Ovarian Cancer Innovations Group (OCIG) Reception during the AACR Special Conference on #OvarianCancer! 💫 It was inspiring to connect with so many passionate researchers in Denver. Let’s keep the momentum going! #AACR #CUAnschutz
@uccc-gorg.bsky.social
September 23, 2025 at 4:04 PM
Congrats to Dr. Liz Woodruff (Division of Repro Science) on receiving a $10K Cancer Innovation Pilot Grant from
@cucancercenter.bsky.social!
Her study explores how social stress/isolation impacts high-grade serous carcinoma (HGSC) progression & immune response🎉 @liz-woodruff.bsky.social #CUAnschutz
September 23, 2025 at 3:00 PM
🎗️Attending the AACR Conference on Ovarian Cancer?

Visit Alan Elder’s poster "Discerning mechanisms of SEMA7A in therapy resistance & tumor progression in HGSC"

Also join the CU Ovarian Cancer Innovations Group (OCIG) Reception on Saturday, Sept 20th. Register here: bit.ly/47KvpA3

#AACRovca25
September 15, 2025 at 4:54 PM
🎉Dr. Kian Behbakht from CU's Ovarian Cancer Innovations Group (OCIG) was featured on #BBC The Happy Pod🎙️He discussed the development of an ovarian cancer early detection test, which is being developed in partnership with AOA Dx. #OvarianCancer #CUAnschutz

👉 Listen here: www.bbc.com/audio/play/p...
BBC Audio | Global News Podcast | The Happy Pod: The 'game changing' test for ovarian cancer
Happy stories and positive news from around the world - our weekly collection
www.bbc.com
September 8, 2025 at 8:24 PM
Drs. Ben Bitler & Kian Behbakht, AOA Dx (a women-owned Denver biotech), and other GynOnc researchers co-published a study on a scalable, sensitive test using lipidomic and protein biomarkers with machine learning to improve early ovarian cancer detection. View Here: www.mdpi.com/2075-4418/15...
www.mdpi.com
September 2, 2025 at 4:02 PM
Help us welcome Drs. Katharine Linder and Daisy Cruz, our new CU GynOnc fellows joining the University of Colorado GynOnc Research Group (GORG) Lab this Fall 2025! Excited for the expertise and passion they'll bring to advancing women’s cancer research 🎉🎉 #GynOnc #CUAnschutz #OvarianCancer
August 18, 2025 at 6:14 PM
🎉Dr. Lindsay Brubaker is tackling therapy resistance in #HGSC with cutting-edge research on antibody-drug conjugates (ADCs). Backed by a competitive DOD grant, her study explores epigenetic drivers to expand and improve treatment options. View Article bit.ly/4fxHr1E #OvarianCancer #CUAnschutz
August 11, 2025 at 4:48 PM
Congrats to Drs. Ben Bitler and Jim Lambert on receiving an award from Golfers Against Cancer to advance ovarian cancer immunogenic cell death (ICD) research — pushing boundaries in cancer research #OvarianCancer #GynOnc #CUAnschutz 👏👏 @uccc-gorg.bsky.social
August 5, 2025 at 7:35 PM
Congrats to Scott Lin, MD, PhD Candidate, on receiving the Cancer Biology T32 award from the National Cancer Institute! This prestigious award supports 5 predoctoral students each year with funding through the University of Colorado Cancer Center. 🎉🎉 #CUAnschutz #GynOnc @uccc-gorg.bsky.social
July 31, 2025 at 8:26 PM
🔬Don’t miss Session 2 of our gynecologic cancer virtual series! Scott Lin, MD, PhD Candidate, will share insights on PARP inhibitors & ovarian cancer treatment. #OvarianCancer @uccc-gorg.bsky.social

📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
June 25, 2025 at 7:17 PM
Congrats to Team Bitler—Drs. Bitler, Corr, Sikora, Clauset, and many others—2025 CU ASPIRE Awardees🎉Their SPORE effort to advance ovarian cancer care with novel therapies & population science. #OvarianCancer #CUAnschutz @uccc-gorg.bsky.social@mjsikora.bsky.social View details here: Bit.ly/4mWBRsO
June 17, 2025 at 3:47 PM
Congratulations to Courtney Bailey, PhD student in Biomedical Engineering at CU Boulder and part of the Gynecologic Oncology Research Group at CU Anschutz! She was awarded the Achievement Reward for College Scientist Scholarship. Well deserved! 👏 #CUAnschutz #CUBoulder #BiomedicalEngineering #GynOnc
June 11, 2025 at 6:40 PM